Northern Clinical Trial Coordinators Oy

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Depression1 trial
• Lupus (SLE)1 trial
• Systemic sclerosis (scleroderma)1 trial

Phase

• Phase 33 trials

Status

• Recruiting2 trials
• Completed1 trial

Lead sponsor

• Boehringer Ingelheim1 trial
• Janssen Cilag International1 trial
• Janssen Research & Development, LLC1 trial

Running trials

• Recruiting

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

  NCT07438496· Phase 3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lupus (SLE)1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting

Closed trials

• Completed

  A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants with Major Depressive Disorder (MDD) with Moderate-to-Severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and an Open- labeled Long-term Extension Treatment with Aticaprant

  2024-511557-21-00· Phase 3· Janssen Cilag International· Source